Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G9077Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G9077

G9077 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project).

It was added to HCPCS effective 01/01/2006, and its current record took effect 01/01/2007.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Onc dx prostate t1no progres
Date added
01/01/2006
Action effective
01/01/2007
BETOS
P7B

Related G90xx codes

Common questions about G9077

Is HCPCS G9077 still valid?

Yes. G9077 is active in the CMS October 2026 HCPCS file.

Does Medicare cover G9077?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.